Abstract:BACKGROUND:Primary and metastatic cancers that affect bone are frequently associated with severe and intractable pain. The mechanisms underlying the development of bone cancer pain are largely unknown. The aim of this study was to determine whether enhanced excitability of primary sensory neurons contributed to peripheral sensitization and tumor-induced hyperalgesia during cancer condition. In this study, using techniques of whole-cell patch-clamp recording associated with immunofluorescent staining, single-cell reverse-transcriptase PCR and behavioral test, we investigated whether the intrinsic membrane properties and the excitability of small-sized dorsal root ganglion (DRG) neurons altered in a rat model of bone cancer pain, and whether suppression of DRG neurons activity inhibited the bone cancer-induced pain.RESULTS:Our present study showed that implantation of MRMT-1 tumor cells into the tibial canal in rats produced significant mechanical and thermal hyperalgesia in the ipsilateral hind paw. Moreover, implantation of tumor cells provoked spontaneous discharges and tonic excitatory discharges evoked by a depolarizing current pulse in small-sized DRG neurons. In line with these findings, alterations in intrinsic membrane properties that reflect the enhanced neuronal excitability were observed in small DRG neurons in bone cancer rats, of which including: 1) depolarized resting membrane potential (RMP); 2) decreased input resistance (Rin); 3) a marked reduction in current threshold (CT) and voltage threshold (TP) of action potential (AP); 4) a dramatic decrease in amplitude, overshot, and duration of evoked action potentials as well as in amplitude and duration of afterhyperpolarization (AHP); and 5) a significant increase in the firing frequency of evoked action potentials. Here, the decreased AP threshold and increased firing frequency of evoked action potentials implicate the occurrence of hyperexcitability in small-sized DRG neurons in bone cancer rats. In addiotion, immunofluorescent staining and single-cell reverse-transcriptase PCR revealed that in isolated small DRG neurons, most neurons were IB4-positive, or expressed TRPV1 or CGRP, indicating that most recorded small DRG neurons were nociceptive neurons. Finally, using in vivo behavioral test, we found that blockade of DRG neurons activity by TTX inhibited the tumor-evoked mechanical allodynia and thermal hyperalgesia in bone cancer rats, implicating that the enhanced excitability of primary sensory neurons underlied the development of bone cancer pain.CONCLUSIONS:Our present results suggest that implantation of tumor cells into the tibial canal in rats induces an enhanced excitability of small-sized DRG neurons that is probably as results of alterations in intrinsic electrogenic properties of these neurons. Therefore, alterations in intrinsic membrane properties associated with the hyperexcitability of primary sensory neurons likely contribute to the peripheral sensitization and tumor-induced hyperalgesia under cancer condition.

Overexpression of Suppressor of Cytokine Signaling 3 in Dorsal Root Ganglion Attenuates Cancer-Induced Pain in Rats

Molecular mechanisms underlying the effect of intrathecal LV-SOCS3injection on pain behaviors in a rat model of bone cancer

Effects of Ghrelin on Pgsk-3Β and Β-Catenin Expression when Protects Against Neuropathic Pain Behavior in Rats Challenged with Chronic Constriction Injury

Role of the CXCR4/ALK5/Smad3 Signaling Pathway in Cancer-Induced Bone Pain

Increased expression of acid-sensing ion channel 3 within dorsal root ganglia in a rat model of bone cancer pain

Upregulation of Lncrna-Nonratt021203.2 in the Dorsal Root Ganglion Contributes to Cancer-Induced Pain Via CXCL9 in Rats.

Identification of Lncrna and Mrna Expression Profiles in Dorsal Root Ganglion in Rats with Cancer-Induced Bone Pain.

Effects of intrathecal injection of SOCS3 on pain behavior and expression of proinflammatory cytokines in mice with neuropathic pain

Enhanced Binding Capability of Nuclear Factor-Κb with Demethylated P2X3 Receptor Gene Contributes to Cancer Pain in Rats

Functional up-regulation of P2X3 receptors in dorsal root ganglion in a rat model of bone cancer pain

Schwann Cell-Derived CXCL2 Contributes to Cancer Pain by Modulating Macrophage Infiltration in a Mouse Breast Cancer Model

Downregulation of Microrna-218 Relieves Neuropathic Pain by Regulating Suppressor of Cytokine Signaling 3.

Interleukin-6-mediated functional upregulation of TRPV1 receptors in dorsal root ganglion neurons through the activation of JAK/PI3K signaling pathway: roles in the development of bone cancer pain in a rat model.

Upregulation of bone morphogenetic protein 2 ( Bmp2) in dorsal root ganglion in a rat model of bone cancer pain.

Down-Regulation of NOX4 Expression in Dorsal Horn of Spinal Cord Could Alleviate Cancer-Induced Bone Pain in Rats by Reducing Oxidative Stress Response.

Abstract PR350: Overexpression of Gdnf in the Spinal Cord Alleviates Cutaneous Hyperalgesia But Not Spontaneous Pain in A Rat Model of Bone Cancer Pain

Activation of the BMP2-SMAD1-CGRP Pathway in Dorsal Root Ganglia Contributes to Bone Cancer Pain in a Rat Model

Bilateral Downregulation of Nav1.8 in Dorsal Root Ganglia of Rats with Bone Cancer Pain Induced by Inoculation with Walker 256 Breast Tumor Cells

Enhanced Excitability of Small Dorsal Root Ganglion Neurons in Rats with Bone Cancer Pain.

Induction of Suppressor of Cytokine Signaling 3 Via HSF-1-HSP70-TLR4 Axis Attenuates Neuroinflammation and Ameliorates Postoperative Pain.

Inhibition of Glial Activation in Rostral Ventromedial Medulla Attenuates Mechanical Allodynia in a Rat Model of Cancer-Induced Bone Pain